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Essentials 
 
x Thromboprophylaxis after lower limb injury is often based on complex risk stratification. 
x Our systematic review identified variables predicting venous thromboembolism (VTE) in 
this group. 
x Age and injury type were commonly reported to increase the odds of VTE (Odds Ratio 1.5 to 
3.48).  
x We found limited evidence to support the use of other risk factors within prediction models.  
 
Summary 
 
Background 
Patients immobilised after lower limb injury are at risk of venous thromboembolism (VTE). 
There is international variation in the use of thromboprophylaxis for such patients. Risk based 
strategies have been adopted to aid decision making in many settings. The accuracy of these 
strategies is unclear.    
 
Objectives 
A systematic review was undertaken to identify all individual patient identifiable risk factors 
linked to any VTE outcome following lower limb immobilisation.  
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Methods 
Several electronic databases were searched from inception to May 2017.  Any studies which 
included a measurement of VTE patient outcome in adults requiring temporary immobilisation 
(e.g. leg cast or brace in an ambulatory setting) for an isolated lower limb injury and reported 
risk factor variables were included.  Descriptive statistics and thematic analysis were used to 
synthesise the evidence. 
 
Results 
Our database search returned 4771 citations, of which 15 studies reporting outcome data on 
80,678 patients were eligible for analysis. Risk factor associations were reported through 
regression analyses, non-parametric tests and descriptive statistics. All studies were assessed as 
at moderate or serious risk of bias using the ROBINS-I risk of bias tool.  
Advancing age and injury type were the only individual risk factors demonstrating a 
reproducible association with increased symptomatic and/or asymptomatic VTE rates. Several 
risk factors currently used in scoring tools did not appear to be robustly evaluated for 
subsequent association with VTE, within these studies.  
 
Conclusions 
Clinicians should be aware of the limited evidence to support individual risk factors in guiding 
thromboprophylaxis use for this patient cohort.  
 
Summary (Additional) 
 
Funding 
This study was funded by the United Kingdom National Institute for Health Research Health 
Technology Assessment Programme (project number 15/187/06).   
 
 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
PROSPERO  Registration 
Pandor A, Goodacre S, Horner D, Stevens JW, Clowes M, Davis S, Stevenson M. Systematic review 
and cost-effectiveness analysis of thromboprophylaxis for lower limb immobilisation. 
PROSPERO 2017 CRD42017058688. Available at: 
http://www.crd.york.ac.uk/PROSPERO/display_record.php?ID=CRD42017058688 
 
Keywords 
 
Risk 
Immobilization 
Venous thromboembolism 
Casts, surgical  
 
BACKGROUND 
 
Venous thromboembolic (VTE) disease is a major global cause of morbidity and mortality.[1, 2] 
An estimated 10 million episodes are diagnosed yearly; over half of these episodes are 
provoked by hospital admission or procedure and result in significant loss of disability adjusted 
life years.[3] As a result, there has been sustained focus on prevention over the last two 
decades.[4-6] However, there are still patient groups where the balance of benefit and risk from 
thromboprophylaxis remains unclear.  
 
Outpatients placed in temporary lower limb immobilisation following injury are one such 
cohort. Approximately 70,000 such patients are discharged from UK emergency departments 
each year, with an overall symptomatic VTE rate approaching 2%.[7-9] Some of these events are 
fatal, leading to natural reflection on prevention strategies and occasional coronial 
recommendations.[10, 11] Wide variation in practice regarding the use of immobilisation 
(plaster cast, hinged brace or protective boot) and the use of thromboprophylaxis continues for 
these patients.[12-14] International guidance offers conflicting advice, from no intervention, 
through pragmatic shared decision making all the way up to routine pharmacological 
thromboprophylaxis.[7, 15, 16] This lack of consensus fosters clinical uncertainty.   
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The low symptomatic VTE event rate, financial implications, opportunity costs and clinical risks 
of therapy may be cited as reasons to avoid routine thromboprophylaxis. There are several 
studies which also suggest that in cohorts without overt additional risk factors, the incidence of 
clinically relevant VTE in immobilised ambulatory patients is negligible.[13, 17] As such, recent 
evidence has begun to focus on discrimination through scoring systems and risk assessment 
models, to promote tailored thromboprophylaxis to those most likely to benefit.[18] Most 
scores focus on risk factors relevant to inpatients; it is plausible that these same risk factors 
increase the likelihood of VTE in ambulatory patients with lower limb immobilisation, but this 
has not been formally evaluated.   
 
Despite publication of three risk assessment methods for this particular population in the last 
decade, the derivation and validation of these scoring systems is often unclear.[7, 18, 19] 
Included risk factors are often double counted, attributed Ǯǯ in a seemingly arbitrary 
fashion and dichotomised without evidential support. In addition, it is unclear whether these 
scores are designed to detect all VTE; eighty percent of deep vein thrombosis (DVT) can be 
clinically silent initially, a statistic that perhaps explains embolisation accounting for 30% of 
first VTE presentations.[20] The validity of scoring systems and risk factors therefore vary 
depending on the use of routine ultrasound to screen for silent DVT as an outcome, or 
investigation only of those patients with concerning clinical symptoms.  
 
We sought to identify which individual risk factors have been identified within the literature as 
likely to increase the risk of both asymptomatic and symptomatic VTE in patients with 
temporary lower limb immobilisation. We then looked to compare these identified risk factors 
to those highlighted within published risk prediction tools, such as the Guidelines in Emergency 
Medicine Network (GEMNet), Plymouth and Leiden Thrombosis Risk in Plaster-cast (L-TRiP-
cast) rules.[7, 18, 19]     
 
METHODS 
The systematic review was undertaken in accordance with the general principles recommended in the 
Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement.[21] This 
review was part of a larger project on thromboprophylaxis for lower limb immobilisation which was 
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registered on the PROSPERO international prospective register of systematic reviews 
(CRD42017058688). The full protocol is available here.  
 
Data sources and search strategy 
Potentially relevant studies were identified through searches of ten electronic databases 
including MEDLINE (1946 to May 2017), EMBASE (1974 to May 2017), and the Cochrane 
Library (2017, issue 4).  The search strategy used free text and thesaurus terms and combined 
synonyms relating to the condition (e.g. venous thromboembolism in people with lower limb 
immobilisation) with risk factor assessment or risk prediction modelling terms (used in the 
searches of MEDLINE, Cochrane Library and EMBASE only).  Searches were supplemented by 
hand-searching the reference lists of all relevant studies (including existing systematic reviews), 
performing a citation search of relevant articles, contacting key experts in the field and 
undertaking systematic keyword searches of the World Wide Web using the Google search 
engine.  No language or date restrictions were used on any database. Further details on the 
search strategy can be found in Table S1 (supporting information). 
 
Study selection 
All titles were examined for inclusion by one reviewer (AP) and any citations that clearly did not 
meet the inclusion criteria (e.g. non-human, unrelated to venous thromboembolism) were excluded.  
All abstracts and full text articles were then examined independently by two reviewers (AP and DH).  
Any disagreements in the selection process were resolved through discussion with a third reviewer 
(SG) and included by consensus. 
   
Studies were considered eligible for inclusion if they met the following criteria: a) any study 
design which included a measurement of VTE patient outcome (symptomatic and/or 
asymptomatic); b) adults (age over 16 years) requiring temporary immobilisation (e.g. leg cast 
or brace in an ambulatory setting) for an isolated lower limb injury c) any studies that reported 
and analysed data on individual risk factors associated with deep vein thrombosis or pulmonary 
embolism.  
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Data extraction and quality assessment 
Data relating to study design, methodological quality and outcomes were extracted by one 
reviewer (AP) into a standardised data extraction form and independently checked for accuracy 
by a second (DH). Any discrepancies were resolved through discussion to achieve agreement. ǡǯȋ
ȌǤ 
 
The methodological quality of each included study was assessed using the Risk Of Bias In Non-
randomized Studies - of Interventions tool (ROBINS-I, formerly called A Cochrane Risk of Bias 
Assessment Tool - for Non-Randomized Studies of Interventions, ACROBAT-NRSI).[22] The tool 
is based on the original Cochrane risk of bias tool for randomised studies [23] and also builds on 
related tools such as QUADAS-2 (Quality Assessment of Diagnostic Accuracy Studies).[24] 
ROBINS-I[22] provides a detailed framework for assessment and judgement of risk of bias 
domains, and has been used previously within the systematic review literature.[25]   
 
All studies were analysed using this tool[22] regardless of whether the original study design 
included randomisation to other exposures, thus ensuring that risk of bias was assessed 
specifically for the comparisons of interest to this review. It is important to note that the quality 
assessment reflects how well a specific result evaluated the association of interest to this 
review, regardless of the objectives of the original study. 
 
Data synthesis and analysis  
We considered VTE to comprise any subsequent recorded diagnosis of asymptomatic or 
symptomatic deep vein thrombosis, pulmonary embolism or death attributable to either 
pathology. We made no attempt to distinguish between anatomical location, thrombus burden 
or clinical sequelae of VTE for this project, in accordance with the definitions of hospital 
acquired thrombosis produced by NHS England (any VTE occurring during hospital admission 
or up to 90 days after admission).[26] Individual risk factors highlighted through regression, 
odds ratio analysis or parametric testing as being significantly associated with an increased, or 
decreased likelihood of subsequent VTE were extracted. In particular, we searched each paper 
for evidence of individual risk factors highlighted within current risk stratification tools and 
recorded their prediction performance when addressed. Other risk factors demonstrating an 
association with asymptomatic or symptomatic VTE in the context of individual studies were 
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also reported. We were unable to perform meta-analysis due to significant levels of 
heterogeneity between studies, variable reporting items and the high risk of attributable bias. 
Descriptive statistics and thematic analysis were used to synthesise risk factors acting in a 
reproducible fashion across studies. All analyses were conducted using Microsoft Excel 2010 
(Microsoft Corporation, Redmond, WA, USA). 
 
RESULTS 
 
Figure 1 summarises the process of identifying and selecting relevant literature.  Of 4771 
citations, 75 full text articles were retrieved and fully assessed; 15 of these studies met all 
inclusion criteria.[27-41] A list of the 60 excluded studies following full text review, with 
reasons for exclusion, is presented in Table S2.  
 
The design and patient characteristics of the included studies[27-41] are summarised in Table 
1. All studies were published between 1993 and 2017. Five were RCTs with conservative 
arms,[27, 28, 32, 33, 41] three were prospective observational cohort or cross-sectional 
studies,[30, 35, 38] one was a case-control study[39] and six were retrospective cohort 
studies)[29, 31, 34, 36, 37, 40], conducted in ten different countries (Australia,[29, 30, 36] 
Canada,[28, 34] China,[41] Denmark,[40] France,[38] Germany,[27, 32, 33] Iran,[35] the 
Netherlands,[39] the UK[31] and the USA).[37] The vast majority of the studies (n=11) were 
entirely outpatient based,[27-33, 35, 36, 38, 41] whereas the remaining studies[34, 37, 39, 40] 
included patients with a short duration inpatient stay to facilitate day case surgery. In total, data 
were collated on 80,678 patients with a subsequent reported outcome of VTE positive or 
negative following temporary lower limb immobilisation. The median prevalence of any VTE 
from the studies was 4.8% (ranging from 0.22%[31] to 23.5%[34]) and the mean age ranged 
from 33.8 years[32] to 52.6 years[40]. The proportion of male subjects ranged from 45.8%[30] 
to 86.1%,[34] with a median across the studies of 56.3%. The median prevalence of 
symptomatic VTE only across all studies with interpretable outcome data (77,261 patients) 
was 2.9%. 
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The duration of follow up varied between studies. Ten studies reported follow up over a period 
of at least three months[28-31, 34, 37-41] and one study followed up patients up to 14 days.[35] 
Although four studies failed to record the duration of follow up,[27, 32, 33, 36] two of these 
appeared to report follow up only for the duration of the plaster cast, which averaged 15.7 
days[33] and 17 days[32] respectively. Eight studies collected data on risk factors prospectively 
via physician assessment or questionnaire,[27, 28, 30, 32, 33, 38, 39, 41] six studies collected 
this data through clinical records, electronic patient notes or registry information.[29, 31, 34, 
36, 37, 40] One study did not report the methodology for this aspect of data collection.[35] 
Analysis and methodology of VTE diagnosis subsequent to immobilisation varied between 
studies, including prospective screening in all patients following plaster removal (seven 
studies),[27, 28, 30, 32, 33, 35, 41] adjudicated diagnostic evaluation in those with symptoms 
(two studies)[38, 39] and retrospective identification of VTE through interrogation of clinical 
records/health databases (six studies).[29, 31, 34, 36, 37, 40] A single study[31] looked only at 
the subsequent diagnosis of pulmonary embolism as an outcome, with predictably reduced 
prevalence. The association of individual risk factors with subsequent VTE was assessed 
through regression analyses (nine studies),[28, 29, 31, 36-41] non-parametric tests (two 
studies)[30, 34] and descriptive statistics (four studies).[27, 32, 33, 35]  
 
The overall methodological quality of the 15 included studies is summarised in Figure 2 and 
Table 2. All studies were deemed to be at overall moderate (seven studies)[27, 28, 32, 33, 37, 
40, 41] or serious (eight studies)[29-31, 34-36, 38, 39] risk of bias, using the ROBINS-I[22] 
framework for assessment and judgement. Studies scoring at serious risk of bias did so 
predominately on selection of participants into the study, perhaps highlighting the issue with 
retrospective observational work into VTE outcomes; patients deemed to be at high risk in 
these cohorts are often individually treated with thromboprophylaxis (as highlighted in Table 
1), or managed in a different manner to other patients, thus reducing the overall reported risk 
in the population. 
 
Age was the most consistent individual risk prediction factor for any VTE outcome, highlighted 
across eleven studies.[28, 30, 32-34, 36-41] Odds ratios reported for age varied from 1.05[41] 
to 3.48[36] with limited estimates of precision. Injury type as a risk factor was highlighted 
across six studies,[28, 32, 33, 36, 38, 39] all using multivariate logistic regression to suggest that 
severe traumatic injuries and fractures (when compared to soft tissue injuries) were 
independently associated with increased risk of VTE. Body mass index (BMI) was the third most 
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consistent individual risk highlighted, noted as independently predictive of VTE across four 
studies [33, 39-41] with odds ratios ranging from 1.2[41] to 17.2.[39] However, six studies 
looked for and found no association between BMI and subsequent VTE. [30, 32, 34, 37, 38, 42]  
 
Both age and BMI feature in the published and most widely used risk prediction models. Injury 
type and severity is featured in the L-TRIP and Plymouth score, but not incorporated within the 
GEMNET guideline as an individual feature. All individual risk factors currently used within the 
above risk stratification tools and their reported association with VTE across all included 
studies, are shown in Table 3. Despite being present within several risk stratification tools, 
pregnancy, recent hospital admission and preceding immobility as individual characteristics 
were not identified and prospectively/retrospectively assessed by any of the included studies. 
As such, these risk factors do not appear to have been evaluated in the literature regarding 
association with subsequent VTE, in patients with temporary lower limb immobilisation after 
injury. 
 
We found similar results when an outcome of symptomatic VTE only was used within studies. 
In addition, we performed a post-hoc analysis excluding studies with less than 90 days follow 
up, or excluding studies at high risk of bias. Age continued to be a consistent predictor of VTE 
risk, highlighted in 8/10 studies and 6/7 studies, respectively. The results of these exclusions on 
other risk factor variables are presented in tables S3 and S4.  
 
We found few other individual risk factors in this study not included in current scoring systems, 
but associated with subsequent development of VTE after lower limb immobilisation. These 
included recent air travel (one study),[29] coagulopathy and peripheral arterial disease (one 
study).[40] A single paper looked at the cumulative incidence of clinical risk factors per patient 
and reported the presence of three or more factors to be significantly associated with 
development of VTE.[35]  
 
Methodology of reporting individual variables to have no association with subsequent VTE was 
inconsistent and heterogeneous. Six studies reported no association between gender and 
VTE;[28, 30-32, 36, 39] five studies reported no association between exogenous oestrogen use 
and VTE;[30, 32-34, 42] six studies reported no association between smoking and subsequent 
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VTE.[30, 32, 34, 38, 42, 43] Several papers produced conflicting results; six studies reported no 
association between raised BMI and subsequent risk of VTE [30, 32, 34, 37, 38, 42] and one 
study reported no association with increasing age.[31] These other identified risk factors and all 
negative associations are reported in Table 4.  
 
DISCUSSION 
 
In this systematic review of risk factors associated with VTE following temporary lower limb 
immobilisation after injury, we found that only advancing age was consistently highlighted as a 
risk factor for VTE across the majority of included studies. Injury type showed weaker 
association, with consistent association across six studies. All studies were deemed to be at 
moderate or serious risk of bias overall following structured quality assessment. These findings 
raise questions regarding the reliability of using individual risk factors to determine subsequent 
VTE risk in this cohort.  
 
Our study is the first systematic review to assess the link between individual risk factors and all 
VTE i.e. symptomatic and/or asymptomatic following temporary lower limb immobilisation 
after injury. This is an important distinction, as our population of interest differs from generic 
thrombosis datasets; patients with lower limb injury are potentially younger, more active and 
devoid of comorbidity than those presenting with other forms of VTE.[44] Our study was 
conducted with robust methodology and was undertaken in accordance with guidelines 
published by the Centre for Reviews and Dissemination. [45] The protocol was registered in 
advance with PROSPERO. Clinical experts were involved throughout to assess the validity and 
applicability of research during the project. We reported descriptive statistics to provide plain 
insight into the limited evidence base applicable to the subject matter, and the scientific 
concerns regarding validity of the data.   
 
Our systematic review returned data from randomised controlled trials, prospective cohorts 
and retrospective health database registries. As such, we were unable to combine data for 
additional analysis of risk or consider performing an individual patient data meta-analysis. 
Despite strict inclusion criteria, the included studies also demonstrated high levels of 
heterogeneity.  
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Several studies included patients receiving operative intervention and short inpatient stays. 
Following the introduction of guidance on thromboprophylaxis to reduce the risk of hospital 
acquired thrombosis, it is reasonable to assume that in a modern healthcare environment most 
of these patients would receive routine thromboprophylaxis.[46] As such, inclusion of these 
patients could lead to false reassurance regarding low incidence of VTE. However, we 
considered patients with a short inpatient stay (<5 days) to fit within our scope of interest; 
initial thromboprophylaxis in hospital may be inadequate in dose and/or duration, and these 
patients often remain temporarily immobilised for a period of 4-8 weeks in total. Debate also 
persists about the type and duration of thromboprophylaxis in this setting. Outside randomised 
trial data, there was significant heterogeneity in thromboprophylaxis regimens by agent, dose 
and duration. As such, observational cohort studies attempting to link individual risk factors at 
baseline to subsequent VTE diagnosis are at risk of confounding and selection bias. In addition, 
some of the larger datasets reported VTE rates related to risk factors without ascertaining 
which, if any patients, had received prophylaxis. This is a core issue surrounding this topic; 
definitive VTE event rates, associated risk factors and adverse events cannot be accurately 
determined by studying a group of patients, however large, in which clinicians have selected 
higher risk candidates to receive any form of prophylaxis.  
 
Our definition of VTE also masked any subgroup analysis by anatomical location. As such, we 
were unable to comment on clot burden or whether subsequent VTE occurred in the 
injured/immobilised limb. While this latter point is perhaps intuitive, there is additional direct 
clinical relevance to this question; if VTE is more likely to occur in the affected limb, this 
suggests a focal issue from a more generalised prothrombotic state and that modification of 
treatment plans/immobilisation strategies could be more beneficial than generic prophylaxis.   
 
All the studies within our review were classed as at moderate or severe risk of bias. As such, any 
conclusions regarding the influence of risk factors on the subsequent development of VTE 
drawn are based on weak evidence and have the potential to be inaccurate. In addition, several 
studies individually report a lack of power to accurately discriminate whether an individual risk 
factor was not associated with VTE, or whether the sample size precluded statistical association. 
As such, a lack of significant association within a study cannot be interpreted as direct evidence 
against the individual risk factor, without further detailed scrutiny.  
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This is the first systematic review conducted to look directly at individual risk factors increasing 
the risk of VTE in patients with lower limb injury and immobilisation, discharged to an 
outpatient setting. Previous work has attempted to address a similar issue in patients 
undergoing elective foot and ankle surgery.[47-49] We consider this to be a different population 
due to the pathological differences between blunt forced and surgical trauma, expert image 
guided reduction and postoperative immobilisation regimes.  
 
Advancing age has long been recognised as an established risk for VTE. [50] Our findings 
support this as one of the more reliable individual risk factors consistently demonstrating 
association with the likelihood of subsequent VTE. Causation within this study cannot be 
determined due to variable methodology. Indeed, our demonstration of advancing age as a 
consistent individual risk factor for VTE may probably reflects the increasing prothrombotic 
state seen with ageing, irrespective of immobilisation. Although we found conflicting evidence 
on increasing BMI as a risk factor for VTE within this specific cohort of patients, this issue has 
similar face validity. Increased risk is thought to be related to the prothrombotic state induced 
by adipocytes and potential reduction in venous flow through larger veins.[51, 52]  
 
The hypothesis that extent of injury acts as a predictor of VTE risk is in keeping with those 
studies which report a low VTE incidence in patients with immobilisation following soft tissue 
injury.[38] In addition, there is face validity to the idea of a more severe injury leading to 
inflammatory cytokines, prothrombotic changes, endothelial activation and subsequent 
increased predisposition to VTE, in keeping with Virchowǯs triad. However, the challenge 
remains of decoupling the extent of injury from the type of immobilisation; patients with severe 
fracture patterns are more likely to be placed in stricter and more extensive immobilisation. 
Lastly, we found only two studies identifying cumulative risk with an increased incidence of 
VTE. [39, 53] While this is perhaps intuitive, the supporting data appears limited. This could be 
confounded by exclusion criteria for high risk patients within the trials, or the use of 
thromboprophylaxis for patients with multiple risk factors within observational studies. We did 
not look to validate the performance of any proposed risk models within this study.  
 
There are no previous systematic reviews on this topic to which our work can be compared. 
However, several large registries have been recently interrogated in attempt to derive robust 
prediction rules for this population, albeit with some methodological concerns. The most recent 
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is the L-TRiP cast rule, derived from a large population-based case control study of over 10,000 
cases, including 4446 VTE patients.[18] During this study, the authors performed univariate 
analysis on 54 candidate predictor variables in attempt to derive a full, restricted and clinical 
decision rule for use in this population. Age and BMI featured in all 3 models, with odds ratios 
reported on univariate analysis of 3.2 (95% CI 2.9 to 3.6) for age t55 and 3.1 (95% CI 2.5 to 3.9) 
for BMI t35 respectively. No specific candidate variable in this study referred to injury type. 
However, the extent of immobilisation was specifically assessed as a predictor, with odds ratios 
of 10.7 (95% CI 4.3 to 26.6) and 8.7 (95% CI 5.5 to 13.7) for complete leg and lower leg casts 
respectively, when compared to no cast immobilisation. These latter findings perhaps serve as a 
proxy marker of injury severity, and the association with VTE.  
 
The results from the L-TRiP study are in keeping with this systematic review, although it should 
be noted that the highest performing individual risk factor on univariate analysis within the L-
TRiP cohort was use of tamoxifen with an odds ratio of 11.6 (95% CI 3.3 to 41.2). We found no 
evidence from other studies that would support this grade of association. 
 
The findings from this systematic review suggest that while common generic predictors of risk 
for VTE are relevant to the cohort of interest, there is little consistency within the literature 
regarding the value of other candidate variables. In addition, there is poor evidence to support 
the theory of cumulative risk and the existing literature is marred by moderate to serious risk of 
bias. Our work therefore raises questions regarding the validity of current prediction rules in 
clinical use created by expert consensus, without robust external validation. There is a pressing 
need for prospective validation studies in the appropriate cohort of patients to assess the 
sensitivity and specificity of these rules. Complex scoring systems should also be compared to 
those which select patients for thromboprophylaxis on the basis of individual strong generic 
risks (such as advancing age and severe injury), or clinician gestalt.  
 
Our quality assessment overview highlights the limitations of the current literature. As such 
there remains a role for further high quality prospective observational cohort studies on this 
topic, particularly looking at the rarer but more severe VTE risks. This research could include 
pregnant women, those with high risk thrombophilia and those using exogenous oestrogens. 
However, such research will have challenges in a health system with national guidance 
prompting consideration of risk and bespoke prescribing.[7, 46] In addition, the low frequency 
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of events may result in real difficulty obtaining valid datasets. Such studies would need careful 
assessment of baseline risk, transparent reporting of thromboprophylaxis and an independently 
adjudicated, patient-centred outcome measure.  
 
CONCLUSIONS 
We found that increasing age and injury severity only, were the individual risk factors most 
consistently associated with VTE following lower limb immobilisation after acute injury. All 
studies included in the review were deemed at moderate or serious risk of bias. Clinicians 
should be aware of the limited evidence to support individual risk factors in guiding 
thromboprophylaxis use for this patient cohort.  
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Figure Legends: 
 
Figure 1: Flow chart of abstract screening, exclusion and final selection 
Figure 2: ROBINS-I risk of bias assessment graph 
 
 
Table Legends: 
 
Table 1: Study Design and Patient Characteristics of included articles 
Table 2: Quality Assessment Overview 
Table 3:  Identified individual risk factors and their association with developing VTE 
Table 4: Other Identified individual risk factors, their association with developing VTE and narrative 
review. 
Table S1: Literature search strategies 
Table S2: Excluded studies following full text review 
Table S3: Individual risk factors and their reported strength of association with developing VTE 
(Excluding studies with F/up <90 days) 
Table S4: Individual risk factors and their reported strength of association with developing VTE 
(Excluding studies at high risk of bias) 
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Table 1: Summary of design and patient characteristics - Review of individual risk factors associated with VTE risk 
Author 
year, 
country 
Design, 
setting 
Inclusion criteria 
(main) 
Patients, 
sex, age 
(years) 
Incidence of 
VTE 
Prophylaxis  Duration of 
follow-up 
Risk factor 
ascertainme
nt 
Outcome 
ascertainm
ent 
Statistical 
analysis 
Gehling et 
al., 1998; 
Germany  
Design: 
Prospective 
open-label RCT 
 
Setting: 
Outpatient 
Age >16 years 
with lower limb 
injury requiring 
immobilisation 
with plaster or 
bandages (and at 
least one risk 
factor for VTE) 
N=287 
50.5% male 
Mean age: 
36.3a  
LMWH group: 
6.3% 
Aspirin group: 
4.8% 
NR NR Physician 
assessment 
(prospective)  
Clinical 
assessment, 
screening 
sonography 
and 
confirmatio
n 
phlebograph
y  
NR (appears 
descriptive) 
Goel et al., 
2009; 
Canada 
Design: 
Prospective 
double-blind 
RCT  
 
Setting: 
Outpatient 
Adults 18 to 75 
years with 
unilateral 
displaced 
fractures below 
the knee requiring 
operative 
intervention 
N=238 
62% male 
Mean age: 
40.5a 
LMWH group: 
8.7% 
Control group: 
12.6%  
No 
prophylaxis 
prior to 
randomisatio
n 
Minimum of 3 
months 
following 
surgery or 
until the 
fracture had 
united.  
Physician 
assessment 
(prospective) 
Clinical 
assessment 
and bilateral 
lower leg 
venography 
for all 
patients 
Univariate and 
multivariate 
logistic 
regression 
Kock et al., 
1995; 
Germany 
Design: 
Prospective 
open-label RCT  
 
Setting: 
Outpatient 
Adults 18 to 65 
years undergoing 
conservative 
treatment for 
below knee injury 
with cylinder or 
below knee cast 
N=339 
61% male 
Mean age: 
33.8a 
LMWH group: 
0% 
Control group: 
4.3% 
No 
prophylaxis 
prior to 
randomisatio
n 
NR (however, 
duration of 
casting: 
LMWH group, 
15.2 days; 
Control 
group, 18.8 
days) 
Physician 
assessment 
(prospective) 
Clinical 
assessment, 
screening 
sonography 
and 
confirmatio
n 
phlebograph
y 
NR (appears 
descriptive) 
Kujath et al., 
1993; 
Germany 
Design: 
Prospective 
open-label RCT  
 
Setting: 
Outpatient 
Age >16 years 
undergoing 
conservative 
treatment for 
lower limb injury 
with below knee 
plaster applied for 
N=253 
58% male 
Mean age: 
34.3a 
LMWH group: 
4.8%  
Control group: 
16.5%  
No 
prophylaxis 
prior to 
randomisatio
n 
NR  
(however, 
duration of 
casting: 
LMWH group, 
15.6 days; 
Control 
Physician 
assessment 
(prospective) 
Compressio
n 
ultrasound 
by 2 
examiners 
and 
confirmatio
NR (appears 
descriptive) 
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>7 days group, 15.8 
days) 
n 
phlebograph
y 
Zheng et al., 
2017; China 
Design: 
Prospective 
double-blind 
RCT  
 
Setting: 
Outpatient 
Adults >18 years 
with any fracture 
of the lower limb 
requiring 
operative 
treatment 
N=814 
62.3% male 
Mean age: 
47.8 
LMWH group: 
1.5% 
Control group: 
3.2%  
No 
prophylaxis 
prior to 
randomisatio
n 
3 months Physician 
assessment 
(prospective) 
Blinded 
bilateral 
Doppler 
compressio
n 
ultrasound 
Logistic 
regression 
Riou et al., 
2007; 
France 
Design: 
Prospective 
cohort study 
 
Setting: 
Outpatient 
Age >18 years 
with isolated 
lower limb injury 
(below the knee) 
managed 
conservatively 
(immobilisation 
duration >7 days) 
N=2761 
51% male 
Mean age: 
40 
6.4% Antithrombot
ic prophylaxis 
was given to 
61% patients 
3 months Physician 
assessment 
(prospective) 
Adjudicatio
n committee 
Logistic 
regression with 
propensity score 
analysis  
Hanslow et 
al., 2006; 
Australia 
Design: 
Retrospective 
cohort study  
 
Setting: 
Outpatient 
 
Patients who had 
an operative 
intervention to the 
foot or ankle 
N=602 
52% male 
Mean age: 
42.9 
5.3% Antithrombot
ic prophylaxis 
was given to 
31% patients 
4.4 months  Collected 
from clinical 
records 
(retrospective
) 
Case note 
search, 
including 
hospital re-
attendance 
and 
diagnostic 
imaging 
Logistic 
regression 
Jameson et 
al., 2014; UK 
Design: 
Retrospective 
cohort study  
 
Setting: 
Outpatient 
 
Patients with 
isolated unilateral 
closed ankle 
fracture managed 
conservatively 
N=14,777 
47% male 
Mean age: 
46.4 
0.22% (PE 
only) 
No data 
recorded 
3 months NR; assumed 
collected 
from clinical 
records 
(retrospective
) 
Inpatient 
mortality or 
coded 
diagnosis of 
pulmonary 
embolism 
within 90 
days of 
injury 
Logistic 
regression 
Makhdom et 
al., 2013; 
Canada 
Design:  
Retrospective 
cohort study  
All patients 
undergoing 
Achilles tendon 
N=115 
86.1% male 
Mean age: 
23.5% No peri- or 
post-
operative 
3 months Collected 
from 
electronic 
Case note 
search, 
including 
Non-parametric 
testing using 
Fishers exact 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
 
Setting: 
Outpatient 
until surgery, 
short day-case 
stay thereafter 
repair 41 prophylaxis medical 
record system 
(retrospective
) 
hospital re-
attendance 
and 
diagnostic 
imaging 
Meek and 
Tong, 2012; 
Australia 
Design: 
Retrospective 
cohort study  
 
Setting: 
Outpatient 
 
Age >18 years 
with acute lower 
limb injury 
requiring 
temporary 
immobilisation 
(ED discharge 
within 24 hours of 
presentation) 
N=1231 
56.3% male 
Mean age: 
37 
2.9% No 
prophylaxis 
(excluded if 
received at 
any dose) 
NR Electronic 
notes 
screened for 
eligibility by 
one 
investigator 
(retrospective
) 
Case note 
search, 
including 
hospital re-
attendance 
and 
diagnostic 
imaging 
Logistic 
regression 
Patel et al., 
2012; USA 
Design: 
Retrospective 
cohort study  
 
Setting: 
Mostly 
outpatient, 
some with 
short inpatient 
stays (<3 days) 
All patients who 
had Achilles 
tendon rupture 
N=1172 
NR 
Mean age: 
45 
0.77% Nil routine, 
assumed to 
be none 
provided 
3 months Collected 
from 
electronic 
medical 
record system 
(retrospective
) 
Case note 
search, 
including 
hospital re-
attendance 
and 
diagnostic 
imaging 
Logistic 
regression 
Wahlsten et 
al., 2015; 
Denmark 
Design: 
Retrospective 
cohort study  
 
Setting: 
Inpatient or 
outpatient 
Age >18 years 
undergoing an 
operative 
procedure for a 
fracture of the 
foot, ankle, tibia or 
patella 
N=57,619 
51.4% male 
Mean age: 
52.6a 
 
1.0% Routine 
perioperative 
prophylaxis 
with nil post-
operative 
180 days Collected 
from 5 
different 
cross linked 
registries 
(retrospective
) 
Case note 
search, 
including 
hospital re-
attendance 
and 
diagnostic 
imaging 
Multivariate cox 
regression 
van 
Adrichem et 
al., 2014; 
The 
Netherlands 
Design: 
Case-control 
study  
 
Setting:  
Age 18 to 70 years 
with a first VTE 
identified at an 
anticoagulation 
clinic (cases) 
N= 10,567b 
Sex: NR 
Mean age: 
NR 
NR No data 
recorded 
3 months  Participant 
completed 
questionnaire 
(prospective 
collection) 
Case note 
search, 
including 
hospital re-
attendance 
Logistic 
regression 
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Mostly 
outpatient, 
some with 
short inpatient 
stays (<3 days) 
Control group 
identified by 
random dialling 
method (matched 
for sex and age) 
and 
diagnostic 
imaging 
Ho and 
Omari, 
2017; 
Australia 
Design: 
Cross-sectional 
study  
 
Setting: 
Outpatient 
Age >18 years 
with fracture to 
foot/ ankle with 
conservative 
management 
N=72 
45.8% male 
Mean age: 
NR (median: 
38) 
11% Nil routine, 
assumed to 
be none 
provided 
6 months Questionnaire 
(unclear if 
physician or 
patient 
completed) 
Prospective 
compressio
n 
ultrasound  
Parametric and 
non-parametric 
testing with 
bootstrapping 
Manafi Rasi 
et al., 2012; 
Iran 
Design: 
Cross-sectional 
study  
 
Setting:  
Outpatient 
Age >15 years 
with stable foot/ 
ankle fracture or 
grade 3 sprain 
(non-surgical 
treatment) 
N=95 
77.9% male 
Mean age: 
38 
3% NR 7 to 14 days NR Compressio
n 
ultrasound 
by 2 
independent 
examiners  
NR (appears 
descriptive) 
ED, Emergency Department; LMWH, low molecular weight heparin; NR, not reported; RCT, randomised controlled trial; VTE, venous thromboembolism 
 
a Data calculated based on mean of means 
b Sample included 4418 cases and 6149 controls (of these only 227 cases and 76 controls had lower extremity injuries) 
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Table 2:  ROBINS-I ǣǯ
included study - Review of individual risk factors associated with VTE risk 
Study Bias due to 
confounding 
Bias in 
selection of 
participants 
into the study 
Bias in 
classification/ 
measurement of 
interventions 
Bias due to 
deviations from 
intended 
interventions 
Bias due to 
missing data 
Bias in 
measurement 
of outcomes 
Bias in 
selection of 
the reported 
result 
Overalla 
Gehling et al., 1998  LOW LOW MODERATE MODERATE MODERATE MODERATE MODERATE MODERATE 
Goel et al., 2009 LOW LOW LOW LOW LOW LOW MODERATE MODERATE 
Kock et al., 1995 LOW LOW MODERATE MODERATE LOW MODERATE MODERATE MODERATE 
Kujath et al., 1993 LOW LOW MODERATE MODERATE MODERATE MODERATE MODERATE MODERATE 
Zheng et al., 2017 LOW MODERATE LOW LOW MODERATE LOW MODERATE MODERATE 
Riou et al., 2007 MODERATE MODERATE MODERATE SERIOUS MODERATE MODERATE MODERATE SERIOUS 
Hanslow et al., 2006 MODERATE MODERATE MODERATE SERIOUS MODERATE MODERATE MODERATE SERIOUS 
Jameson et al., 2014 MODERATE SERIOUS MODERATE SERIOUS MODERATE MODERATE MODERATE SERIOUS 
Makhdom et al., 2013 SERIOUS SERIOUS MODERATE MODERATE MODERATE MODERATE MODERATE SERIOUS 
Meek and Tong, 2012 MODERATE SERIOUS MODERATE MODERATE MODERATE MODERATE MODERATE SERIOUS 
Patel et al., 2012 MODERATE MODERATE MODERATE MODERATE MODERATE MODERATE MODERATE MODERATE 
Wahlsten et al., 2015 MODERATE MODERATE MODERATE MODERATE MODERATE MODERATE MODERATE MODERATE 
van Adrichem et al., 
2014 
MODERATE SERIOUS SERIOUS SERIOUS MODERATE MODERATE MODERATE SERIOUS 
Ho and Omari, 2017 SERIOUS SERIOUS MODERATE MODERATE SERIOUS MODERATE MODERATE SERIOUS 
Manafi Rasi et al., 2012 SERIOUS MODERATE MODERATE MODERATE MODERATE MODERATE MODERATE SERIOUS 
a Overall risk of bias judgement (equal to the most severe level of bias found in any domain) were judged as: 1) Low risk of bias - study comparable to a well-performed randomised 
trial 2) Moderate risk of bias -sound for a non-randomised study but not comparable to a rigorous randomised trial 3) Serious risk of bias - the study has some important problems 
4) Critical risk of bias - too problematic to provide any useful evidence on the effects of intervention 
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Table 3:  Individual risk factors and their reported strength of association with developing VTE  
Study Risk factors associated with developing VTE 
Permanent  
(present before episode of lower limb immobilisation) 
Transient  
(during injured period) 
Age BMI Activ
e 
cance
r 
Pregn
ancy 
Smokin
g 
Varicos
-ities 
Prior 
or 
family  
history 
of VTE 
Significan
t co-
morbidity 
Known 
thromb
o-
philia 
Exogenou
s 
oestrogen 
therapy 
Recent 
hospital 
admission or 
surgery 
Preceding 
immobilit
y 
Injury 
type 
Immobil
-isation 
type 
Weight 
bearin
g 
status 
USING AN ENDPOINT OF ASYMPTOMATIC VTE, DETECTED BY ROUTINE SCREENING 
Gehling et 
al., 1998 
N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A 
Goel et al., 
2009 
PSARa NSARa NSARa N/A NSARa N/A N/A NSARa NSARa NSARa N/A N/A PSARa N/A N/A 
Kock et 
al., 1995 
PSARb NSARb N/A N/A NSARb NSARb N/A N/A N/A NSARb N/A N/A PSARb PSARb N/A 
Kujath et 
al., 1993 
PSARc PSARc N/A N/A N/A PSARc N/A N/A N/A N/A N/A N/A PSARc N/A N/A 
Zheng et 
al., 2017 
PSARd PSARd N/A N/A N/A N/A N/A NSARd N/A N/A N/A N/A N/A NSARd N/A 
Ho and 
Omari, 
2017 
PSARe NSARe N/A N/A NSARe N/A NSARe N/A N/A NSARe N/A N/A N/A NSARe NSARe 
Manafi 
Rasi et al., 
2012 
N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A 
USING AN ENDPOINT OF SYMPTOMATIC VTE, DETECTED BY CLINICAL FOLLOW UP AND TARGETED INVESTIGATION 
Riou et 
al., 2007 
PSARf NSARf N/A N/A NSARf NSARf NSARf NSARf N/A NSARf N/A N/A PSARf PSARf PSARf 
Hanslow 
et al., 
2006 
N/A N/A N/A N/A N/A N/A PSARg PSARg N/A N/A N/A N/A N/A PSARg PSARg 
Jameson 
et al., 
2014 
NSARh N/A N/A N/A N/A N/A N/A PSARh N/A N/A N/A N/A N/A N/A N/A 
Makhdom 
et al., 
2013 
PSARi NSARi N/A N/A NSARi N/A N/A NSARi N/A NSARi N/A N/A N/A N/A N/A 
Meek and 
Tong, 
PSARJ N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A PSARJ NSARJ N/A 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
2012 
Patel et 
al., 2012 
PSARk  NSARk N/A N/A N/A N/A NSARk NSARk N/A N/A N/A N/A N/A N/A N/A 
Wahlsten 
et al., 
2015 
PSARL PSARL PSARL N/A NSARL N/A PSARL N/A N/A PSARL N/A N/A N/A N/A N/A 
van 
Adrichem 
et al., 
2014 
PSAR
m 
PSARm N/A N/A N/A N/A N/A N/A PSARm PSARm N/A N/A PSARm N/A N/A 
 
PSAR, Positive significant association reported; NSAR No significant association reported; N/A No attempt to report or analyse in the published manuscript; BMI, body mass index; CI, confidence interval;  LMWH, low 
molecular weight heparin; VTE, venous thromboembolism; OR, Odds Ratio. 
 
a Multivariate logistic regression - p=0.001 for age, p=0.009 for injury type, otherwise reported as showing no association for the relevant prespecified variables.  
b Descriptive statistics Ȃ comparison of percentages only, with Fishers exact testing. Associated risk factors highlighted in discussion section. Notable that no patients in the LMWH group had a VTE event. 
c Descriptive statistics Ȃ comparison of percentages only. Associated risk factors highlighted in table 2, 3 and discussion section. 
d Binary logistic regression analysis, noting odds ratio of 1.050 (95% CI: 1.014 to 1.088, p=0.007) for advancing age, and of 1.201 (95% CI: 1.034 to 1.395, p=0.016) for high BMI, with no evidence of association between 
comorbidity, immobilisation type or gender and outcome of VTE detected.     
e Direct comparison of percentages using Fisher exact, or continuous variables using independent T test. P=0.011 for age, other identified risk factors all failing to reach predefined significance level. Notable that analysed 
group only N=35.  
f  Logistic regression technique described, suggesting the following associations: odds ratio of 3.14 (2.27 to 4.33) for age>50, 2.70 (1.66 to 4.38) for rigid immobilisation, 4.11 (1.72 to 9.86) for non-weight-bearing and 1.88 
(1.34 to 2.62) for severe injury  
g Descriptive statistics, with p values presented for direct comparisons without mention of statistical test. Significant comorbidity, prior VTE and weightbearing status were noted to be associated with VTE development 
(p=0.04, 0.02 and 0.003 respectively.). Logistic regression also performed, highlighting plaster immobilisation as an independent predictor of risk (no odds ratio presented). 
h Logistic regression analysis using univariate and multivariable analysis. O ? ?Ǥ ? ?ȋ ? ? ?ǣ ?Ǥ ? ? ? ?Ǥ ? ?ǡ ? ?Ǥ ? ? ?Ȍ ? ?. No significant association of age with subsequent PE on 
univariate or multivariate analysis.  
i Fishers exact test used to compare categorical variable. Higher proportional rate of VTE for patients >40 years (p=0.0026). No significant association seen regarding VTE and categorised BMI, co-morbidity and exogenous 
oestrogen use. 
J Multivariable logistic regression - Odds ratio of 3.48 (1.11 to 10.89) for age, and 0.16 (0.03 to 0.80) for soft tissue injury compared to Achilles repair. No association seen between VTE development and gender, 
immobilisation type and length of stay.   
k Categorical variables assessed using fishers exact test; Age >40 deemed to be associated with higher risk (p=0.016). No association with BMI, comorbidity or prior VTE and no presentation of significant odds ratios on 
further multivariable analysis.  
L Multivariable cox regression - Hazard ratios of 1.13 for age, 4.15 for exogenous oestrogens, 6.27 (4.18 to 9.40) for prior VTE, 1.65 (1.12 to 2.42) for active cancer and 2.68 (1.66 to 4.33)  for increased BMI.  
M Adjusted odds ratios reported following binary logistic regression; OR of 12.7 (6.6 to 24.6) for traumatic indication (versus non-traumatic), 18.2 (6.2 to 53.4) for oral contraceptive use, 17.2 (5.4 to 55.2) for obesity and 
23.0 (11.5 to 44.6) for known thrombophilia 
 
 
 
  
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
Table 4:  Other identified individual risk factors and their association with developing VTE 
Study Other risk factors shown to be 
associated with VTE 
Risk factors shown to have no 
association with VTE 
Other key findings / authors conclusions 
Gehling et al., 
1998  
x NR x Unable to demonstrate 
association between cumulative risk 
factors and thrombosis 
Non relevant 
Goel et al., 
2009 
x NR x Gender  
x Comorbidities  
x BMI 
Given the overall number of fractures, it is difficult to define 
a specific type as increasing the risk for DVT, but those of the 
tibial plateau did display a tendency towards higher rates of 
DVT in the study  
Kock et al., 
1995 
x NR x Gender 
x Exogenous oestrogen 
x BMI 
Treatment procedures involving less immobilisation should 
be used whenever possible.  
Kujath et al., 
1993 
x NR x Smoking 
x Prior VTE 
x Exogenous oestrogen 
 
The patients who did not develop a thrombosis had an 
average of 1.24 risk factors, whereas the patients with 
thrombosis had an average of 1.96 risk factors. The patients 
who suffered a thrombosis despite prophylaxis had 2.7 risk 
factors.  
Zheng et al., 
2017 
x NR x NR The study was not statistically powered to properly cull out 
any additional potential risk factors that might affect VTE  
incidence in this population 
Riou et al., 
2007 
x Non weight bearing status 
(OR 4.11, 95% CI: 1.72 to 9.86) 
x No association seen on 
multivariate regression with: 
o VTE development and cancer 
o Exogenous oestrogen and 
comorbidity 
Due to a very low incidence of certain variables (cancer, 
severe diseases and hormonal treatment), the power of the 
study was not sufficient to identify their roles as potential 
risk factors. Because the incidence of obesity was not high in 
study population, the results may not apply to morbidly 
obese patients  
Hanslow et al., 
2006 
x Air travel (multivariate 
logistic regression) 
x History of rheumatoid 
arthritis (multivariate logistic 
regression) 
x Tourniquet use and mode of 
anaesthesia for those undergoing 
operative intervention 
The incidence of thromboembolic disease after foot and 
ankle surgery could be higher than that previously reported 
particularly if a patient has certain risk factors  
Jameson et al., 
2014 
x Charlson score of t1 gives an 
OR of 11.97 (95% CI: 5.14 to 27.87, 
x Age 
x Gender 
Comorbidities elevate the risk of PE and these data can be 
utilised by clinicians when considering whether to prescribe 
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p<0.001) LMWH for VTE prophylaxis with the attendant risks of the 
therapy itself borne in mind.  
Makhdom et 
al., 2013 
x NR x Smoking 
x BMI 
x Exogenous oestrogen use 
x Steroid use 
Patient education is necessary regarding anticipated 
complications, and early mobilisation should be advocated, 
especially for patients older than 40 years of age. 
Meek and 
Tong, 2012 
x Achilles tendon rupture 
(descriptive) 
x Gender,  
x Soft tissue injury  
x Method of immobilisation 
x Emergency department length 
of stay 
x Surgical intervention. 
Increasing age and a diagnosis of Achilles tendon rupture 
appeared to increase the risk of VTE. 
Patel et al., 
2012 
x NR x Age, comorbidity, Previous VTE, 
BMI, operative intervention 
Congestive heart failure, history of DVT or PE, and obesity 
might be risk factors, but perhaps the study did not have an 
adequate number of patients to show this difference.  
Wahlsten et al., 
2015 
x Coagulopathy (HR 2.47, 95% 
CI: 1.1 to 5.7) 
x Peripheral arterial disease 
(HR 2.34, 95% CI: 1.2 to 4.6) 
x nonsteroidal anti-
inflammatory drugs use (HR 1.3, 95% 
CI: 1.1 to 1.6) 
x Smoking. 
x Statin therapy and use of ACE 
inhibitor medications appeared to 
convey a protective effect, with HR 0.8 
and 0.6 respectively.  
Patients with risk factors, especially previous DVT or PE, use 
of oral contraceptives, and extreme obesity, have an 
increased risk of DVT/PE that exceeds the risk of DVT/PE in 
healthy patients undergoing total hip or knee replacement  
van Adrichem 
et al., 2014 
x The presence of 2 or more 
acquired or genetic risk factors in 
patients with below knee cast 
immobilisation produced an OR of 
43.4 (95% CI: 13.4 to 141.0)  
x Gender Patients with below-knee cast immobilisation have a 
substantially increased risk of venous thrombosis, i.e. a 56-
fold increased risk as compared with patients with no cast, 
corresponding to an estimated incidence of 1% in the first 3 
months after cast application 
Ho and Omari, 
2017 
x Subsequent presentation with 
symptoms suggestive of DVT 
(p=0.006) 
x Gender 
x BMI 
x Type of injury  
x Type of immobilisation  
x Weight bearing status  
x Smoking  
x Exogenous oestrogen use  
This pilot study unveiled limitations and logistical issues to 
be addressed in the future. Notably, the limitations include 
the small number of patients and the low adherence to 
attending ultrasound assessment.  
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x Family history of VTE 
Manafi Rasi et 
al., 2012 
x Cumulative number of risk 
factors - presence of 3 or more risk 
factors reported as significantly 
associated with VTE development 
(p=0.01) 
NR The incidence of DVT significantly increased in the presence 
of 3 or more risk factors (p=0.01) 
ACE, angiotensin-converting-enzyme; BMI, body mass index; CI, confidence interval;  DVT, deep vein thrombosis; HR, hazard ratio; LMWH, low molecular weight 
heparin; NR, Not reported or analysed; OR, odds ratio; PE, pulmonary embolism; VTE, venous thromboembolism 
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